Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Muscles can make their own androgens, which may help muscle growth.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Androgen use may increase the risk of stroke, but more research is needed.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Finasteride doesn't affect erections much, but may decrease libido in men.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Choosing the right model order in brain connectivity analysis can affect the detection of differences between healthy individuals and those with seasonal affective disorder.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.